Thiazolopyrimidines and their use as modulators of chemokine receptor activity
申请人:Bonnert Roger
公开号:US06958343B2
公开(公告)日:2005-10-25
Compounds of formula (I):
are described herein. The compounds can be used, for example, in the treatment of chemokine mediated diseases, including inflammatory diseases such as psoriasis and COPD.